United Community Bank’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.63M Buy
11,719
+390
+3% +$54.6K 0.54% 49
2025
Q4
$1.39M Buy
11,329
+467
+4% +$56.8K 0.53% 45
2025
Q3
$1.21M Buy
10,862
+4,448
+69% +$506K 0.37% 58
2025
Q2
$711K Sell
6,414
-358
-5% -$38.1K 0.24% 88
2025
Q1
$759K Buy
6,772
+639
+10% +$65.9K 0.28% 88
2024
Q4
$567K Buy
6,133
+35
+0.6% +$3.15K 0.22% 102
2024
Q3
$511K Buy
6,098
+145
+2% +$11.1K 0.2% 110
2024
Q2
$408K Buy
5,953
+3,156
+113% +$211K 0.17% 117
2024
Q1
$205K Buy
2,797
+38
+1% +$2.92K 0.08% 176
2023
Q4
$224K Sell
2,759
-110
-4% -$8.56K 0.09% 166
2023
Q3
$215K Buy
+2,869
New +$221K 0.11% 145

Other funds holding GILD

United Community Bank's GILD Position: Q1 2026 in Review

United Community Bank increased its Gilead Sciences (GILD) stake by 3.4% in Q1 2026, buying an estimated $54.6K and bringing the position to 11,719 shares worth $1.63M. The position accounts for 0.54% of the portfolio, ranked #49.

United Community Bank first reported a position in GILD in Q3 2023 and has held it in 11 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • United Community Bank held 11,719 shares of Gilead Sciences worth $1.63M as of Q1 2026.
  • United Community Bank bought 390 Gilead Sciences shares in Q1 2026, an estimated $54.6K.
  • Gilead Sciences made up 0.54% of United Community Bank's portfolio in Q1 2026, its #49 holding.
  • United Community Bank first reported a position in Gilead Sciences in Q3 2023 and has held it in 11 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on United Community Bank's 13F filing for Q1 2026, filed 24 Apr 2026.